专利检索 ap:("Nalpropion Pharmaceuticals, Inc.") AND inv:"TOLLEFSON, Gary" 第 1 页

1.

发明授权
COMPOSITION AND METHODS FOR INCREASING INSULIN SENSITIVITY 有权

公开(公告)号：EP3132792B1

公开(公告)日：2019-09-11

申请号：EP16179626.3

申请日：2006-11-20

申请人： Nalpropion Pharmaceuticals, Inc.

发明人： COWLEY, Michael A. , MCKINNEY, Anthony A. , TOLLEFSON, Gary

IPC分类号： A61K31/00 , A61K31/135 , A61K31/138 , A61K31/423 , A61K31/4525 , A61K31/485 , A61K31/55 , A61K31/551 , A61K31/7048 , A61K45/06 , A61P3/10 , A61K38/28 , A61K31/445 , A61K31/519 , A61K31/5415 , A61K31/5513 , A61K31/554 , A61K31/35 , A61K31/137 , A61K31/357

2.

发明公开
METHODS OF PROVIDING WEIGHT LOSS THERAPY IN PATIENTS WITH MAJOR DEPRESSION 审中-公开

公开(公告)号：EP3659604A1

公开(公告)日：2020-06-03

申请号：EP19199374.0

申请日：2011-01-10

申请人： Nalpropion Pharmaceuticals, Inc.

发明人： DUNAYEVICH, Eduardo , TOLLEFSON, Gary

IPC分类号： A61K31/485 , A61K31/137 , A61P3/04

摘要： Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.